Journal
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26
Volume 26, Issue -, Pages 667-687Publisher
ANNUAL REVIEWS
DOI: 10.1146/annurev-cellbio-100109-103948
Keywords
cardiovascular disease; congenital heart disease; coronary disease; embryonic stem cells; genetics; induced pluripotent stem cells; myocardial infarction
Categories
Funding
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091209] Funding Source: NIH RePORTER
- NHLBI NIH HHS [K08 HL091209] Funding Source: Medline
Ask authors/readers for more resources
The past few years have witnessed remarkable advances in stem cell biology and human genetics, and we have arrived at an era in which patient-specific cell and tissue models are now practical. The recent identification of cardiovascular progenitor cells, as well as the identification of genetic variants underlying congenital heart disorders and adult disease, opens the door to the development of human models of human cardiovascular disease. We review the current understanding of the contribution of progenitor cells to cardiogenesis and outline how pluripotent stem cells can be applied to the modeling of cardiovascular disorders of genetic origin. A key challenge will be to implement these models in an efficient manner to develop a molecular understanding of how genes lead to disease and to screen for genes and drugs that modify the disease process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available